May 22, 2020 / 12:50 PM / 9 days ago

BRIEF-Sinovac Secures $15 Mln In Funding To Accelerate COVID-19 Vaccine Development

May 22 (Reuters) - Sinovac Biotech Ltd:

* SINOVAC SECURES $15 MILLION IN FUNDING TO ACCELERATE COVID-19 VACCINE DEVELOPMENT

* SINOVAC BIOTECH LTD - ADVANTECH CAPITAL AND VIVO CAPITAL HAVE INVESTED $15 MILLION IN SINOVAC RESEARCH AND DEVELOPMENT

* SINOVAC BIOTECH LTD - TWO INVESTORS EACH LOANED $7.5 MILLION IN FORM OF CONVERTIBLE LOAN THAT BEARS INTEREST

* SINOVAC BIOTECH - RECEIVED APPROVAL FROM GOVERNMENTAL AUTHORITIES TO CONDUCT BOTH PHASE I & PHASE II HUMAN CLINICAL TRIALS FOR CORONAVAC IN CHINA

* SINOVAC BIOTECH - PHASE I CLINICAL TRIAL, WHICH EVALUATES SAFETY, TOLERANCE, PRELIMINARY IMMUNOGENICITY OF CORONAVAC, COMMENCED IN APRIL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below